Tsu, Japan

Masao Yuda


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2005-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masao Yuda: Innovator in Platelet Aggregation Inhibition

Introduction

Masao Yuda is a prominent inventor based in Tsu, Japan. He has made significant contributions to the field of medicine, particularly in the development of proteins that inhibit platelet aggregation. His work has the potential to impact treatments for serious cardiovascular conditions.

Latest Patents

Masao Yuda holds 2 patents related to his research. His latest patents include the Ti-4 protein derived from Triatoma infestans, which exhibits activity to inhibit platelet aggregation. This invention provides the Ti-4 protein and the corresponding gene encoding it. The Ti-4 protein shows promise as a medicine that could serve as a platelet aggregation inhibitor, potentially effective for preventing and treating myocardial infarction, pulmonary infarction, and cerebral infarction. Additionally, the Ti-3 protein, also derived from Triatoma infestans, has similar properties and applications. This protein, along with its gene, is designed to inhibit platelet aggregation and could lead to the development of novel platelet aggregation inhibitors.

Career Highlights

Masao Yuda is affiliated with Mie University, where he conducts his research and development work. His innovative approach to studying proteins has garnered attention in the scientific community. His contributions are vital in advancing medical treatments related to cardiovascular health.

Collaborations

Masao Yuda collaborates with notable colleagues, including Akihiro Morita and Haruhiko Isawa. Their combined expertise enhances the research efforts in the field of platelet aggregation inhibition.

Conclusion

Masao Yuda's work in developing proteins that inhibit platelet aggregation represents a significant advancement in medical science. His patents and collaborations highlight his commitment to improving health outcomes for patients at risk of serious cardiovascular events.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…